We developed an efficient CRISPR prime editing protocol and generated isogenic-induced pluripotent stem cell (iPSC) lines carrying heterozygous or homozygous alleles for putatively causal single nucleotide variants at six type 2 diabetes loci (ABCC8, MTNR1B, TCF7L2, HNF4A, CAMK1D, and GCK). Our two-step sequence-based approach to first identify transfected cell pools with the highest fraction of edited cells significantly reduced the downstream efforts to isolate single clones of edited cells. We found that prime editing can make targeted genetic changes in iPSC and optimization of system components and guide RNA designs that were critical to achieve acceptable efficiency. Systems utilizing PEmax, epegRNA modifications, and MLH1dn provided significant benefit, producing editing efficiencies of 36–73%. Editing success and pegRNA design optimization required for each variant differed depending on the sequence at the target site. With attention to design, prime editing is a promising approach to generate isogenic iPSC lines, enabling the study of specific genetic changes in a common genetic background.
Get full access to this article
View all access options for this article.
References
1.
BunielloA, MacArthurJAL, CerezoM, et al.The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res, 2019; 47(D1):D1005–D1012; doi: 10.1093/nar/gky1120
2.
RaoS, YaoY, BauerDE. Editing GWAS: Experimental approaches to dissect and exploit disease-associated genetic variation. Genome Med, 2021; 13(1):41; doi: 10.1186/s13073-021-00857-3
3.
SoldnerF, LaganiereJ, ChengAW, et al.Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell, 2011; 146(2):318–331; doi: 10.1016/j.cell.2011.06.019
NairAK, TraurigM, SutherlandJR, et al.Generation of isogenic hiPSCs with targeted edits at multiple intronic SNPs to study the effects of the type 2 diabetes associated KCNQ1 locus in American Indians. Cells, 2022; 11(9); doi: 10.3390/cells11091446
6.
HottaA, YamanakaS. From genomics to gene therapy: Induced pluripotent stem cells meet genome editing. Annu Rev Genet, 2015; 49:47–70; doi: 10.1146/annurev-genet-112414-054926
7.
LiM, ZhongA, WuY, et al.Transient inhibition of p53 enhances prime editing and cytosine base-editing efficiencies in human pluripotent stem cells. Nat Commun, 2022; 13(1):6354; doi: 10.1038/s41467-022-34045-7
8.
AnzaloneAV, KoblanLW, LiuDR. Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors. Nat Biotechnol, 2020; 38(7):824–844; doi: 10.1038/s41587-020-0561-9
9.
AnzaloneAV, RandolphPB, DavisJR, et al.Search-and-replace genome editing without double-strand breaks or donor DNA. Nature, 2019; 576(7785):149–157; doi: 10.1038/s41586-019-1711-4
10.
ScheneIF, JooreIP, OkaR, et al.Prime editing for functional repair in patient-derived disease models. Nat Commun, 2020; 11(1):5352; doi: 10.1038/s41467-020-19136-7
11.
GaoP, LyuQ, GhanamAR, et al.Prime editing in mice reveals the essentiality of a single base in driving tissue-specific gene expression. Genome Biol, 2021; 22(1):83; doi: 10.1186/s13059-021-02304-3
12.
DomanJL, SousaAA, RandolphPB, et al.Designing and executing prime editing experiments in mammalian cells. Nat Protoc, 2022; 17(11):2431–2468; doi: 10.1038/s41596-022-00724-4
13.
GaoR, FuZC, LiX, et al.Genomic and transcriptomic analyses of prime editing guide RNA-independent off-target effects by prime editors. CRISPR J, 2022; 5(2):276–293; doi: 10.1089/crispr.2021.0080
14.
ChenPJ, HussmannJA, YanJ, et al.Enhanced prime editing systems by manipulating cellular determinants of editing outcomes. Cell, 2021; 184(22):5635.e29–5652.e29; doi: 10.1016/j.cell.2021.09.018
15.
NelsonJW, RandolphPB, ShenSP, et al.Engineered pegRNAs improve prime editing efficiency. Nat Biotechnol, 2022; 40(3):402–410; doi: 10.1038/s41587-021-01039-7
16.
ScholefieldJ, HarrisonPT. Prime editing—An update on the field. Gene Ther, 2021; 28(7–8):396–401; doi: 10.1038/s41434-021-00263-9
17.
LuC, KuangJ, ShaoT, et al.Prime editing: An all-rounder for genome editing. Int J Mol Sci, 2022; 23(17); doi: 10.3390/ijms23179862
18.
KimHK, YuG, ParkJ, et al.Predicting the efficiency of prime editing guide RNAs in human cells. Nat Biotechnol, 2021; 39(2):198–206; doi: 10.1038/s41587-020-0677-y
19.
LiY, ChenJ, TsaiSQ, ChengY. Easy-Prime: A machine learning-based prime editor design tool. Genome Biol, 2021; 22(1):235; doi: 10.1186/s13059-021-02458-0
20.
MathisN, AllamA, KisslingL, et al.Predicting prime editing efficiency and product purity by deep learning. Nat Biotechnol, 2023; doi: 10.1038/s41587-022-01613-7
21.
ChenPJ, LiuDR. Prime editing for precise and highly versatile genome manipulation. Nat Rev Genet, 2022; doi: 10.1038/s41576-022-00541-1
22.
MahajanA, SpracklenCN, ZhangW, et al.Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation. Nat Genet, 2022; 54(5):560–572; doi: 10.1038/s41588-022-01058-3
23.
CostanzoMC, von GrotthussM, MassungJ, et al.The type 2 diabetes knowledge portal: An open access genetic resource dedicated to type 2 diabetes and related traits. Cell Metab, 2023; 35(4):695.e6–710.e6; doi: 10.1016/j.cmet.2023.03.001
24.
HuopioH, ReimannF, AshfieldR, et al.Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1. J Clin Invest, 2000; 106(7):897–906; doi: 10.1172/JCI9804
25.
PaullD, SevillaA, ZhouH, et al.Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells. Nat Methods, 2015; 12(9):885–892; doi: 10.1038/nmeth.3507
26.
HsuJY, GrunewaldJ, SzalayR, et al.PrimeDesign software for rapid and simplified design of prime editing guide RNAs. Nat Commun, 2021; 12(1):1034; doi: 10.1038/s41467-021-21337-7
UntergasserA, CutcutacheI, KoressaarT, et al.Primer3—New capabilities and interfaces. Nucleic Acids Res, 2012; 40(15):e115; doi: 10.1093/nar/gks596
30.
LiH, DurbinR. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics, 2009; 25(14):1754–1760; doi: 10.1093/bioinformatics/btp324
31.
LiH, HandsakerB, WysokerA, et al.The sequence alignment/map format and SAMtools. Bioinformatics, 2009; 25(16):2078–2079; doi: 10.1093/bioinformatics/btp352
32.
LiH, BusquetsO, VermaY, et al.Highly efficient generation of isogenic pluripotent stem cell models using prime editing. Elife, 2022; 11; doi: 10.7554/eLife.79208
33.
SurunD, SchneiderA, MirceticJ, et al.Efficient generation and correction of mutations in human iPS cells utilizing mRNAs of CRISPR base editors and prime editors. Genes (Basel), 2020; 11(5); doi: 10.3390/genes11050511
34.
GaudelliNM, KomorAC, ReesHA, et al.Programmable base editing of A*T to G*C in genomic DNA without DNA cleavage. Nature, 2017; 551(7681):464–471; doi: 10.1038/nature24644
35.
SiegnerSM, KarasuME, SchroderMS, et al.PnB Designer: A web application to design prime and base editor guide RNAs for animals and plants. BMC Bioinformatics, 2021; 22(1):101; doi: 10.1186/s12859-021-04034-6
36.
HabibO, HabibG, HwangGH, et al.Comprehensive analysis of prime editing outcomes in human embryonic stem cells. Nucleic Acids Res, 2022; 50(2):1187–1197; doi: 10.1093/nar/gkab1295
37.
ParkSJ, JeongTY, ShinSK, et al.Targeted mutagenesis in mouse cells and embryos using an enhanced prime editor. Genome Biol, 2021; 22(1):170; doi: 10.1186/s13059-021-02389-w
38.
LiuN, ZhouL, LinG, et al.HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing. Mol Ther Nucleic Acids, 2022; 29:36–46; doi: 10.1016/j.omtn.2022.05.036
39.
FiumaraM, FerrariS, Omer-JavedA, et al.Genotoxic effects of base and prime editing in human hematopoietic stem cells. Nat Biotechnol, 2023; doi: 10.1038/s41587-023-01915-4
40.
AtkinsA, ChungCH, AllenAG, et al.Off-target analysis in gene editing and applications for clinical translation of CRISPR/Cas9 in HIV-1 therapy. Front Genome Ed, 2021; 3:673022; doi: 10.3389/fgeed.2021.673022
41.
TaoJ, BauerDE, ChiarleR. Assessing and advancing the safety of CRISPR-Cas tools: From DNA to RNA editing. Nat Commun, 2023; 14(1):212; doi: 10.1038/s41467-023-35886-6
42.
ZhaoZ, ShangP, MohanrajuP, et al.Prime editing: Advances and therapeutic applications. Trends Biotechnol, 2023; 41(8):1000–1012; doi: 10.1016/j.tibtech.2023.03.004
43.
DomanJL, PandeyS, NeugebauerME, et al.Phage-assisted evolution and protein engineering yield compact, efficient prime editors. Cell, 2023; 186(18):3983.e26–4002.e26; doi: 10.1016/j.cell.2023.07.039
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
